ArcherDX Blog



Sep
29
2015

ArcherDX and BioChain to Provide NGS-characterized FFPE Tumor Samples

BioChain will supply ArcherDX with multiple types of tumor FFPE samples, including NSCLC samples, which will be comprehensively screened for oncogenic fusions, copy number variations (CNVs), single nucleotide variants (SNVs) and insertions/deletions (indels) using the Archer VariantPlexâ„¢ and FusionPlexâ„¢ Solid Tumor assays.


Sep
18
2015

Clinically actionable gene fusions, CNVs and SNVs detected by NGS-based comprehensive tumor profiling

Dr. A. John Iafrate, MD PhD discusses the practical challenges of clinical genotyping and how next-generation sequencing (NGS) and Anchored Multiplex PCR (AMP) technologies address those challenges in the clinic.


Sep
15
2015

Can you trust your gene fusion-negative results?

Orthogonal verification of fusion-negative FFPE samples using Archer FusionPlex assays revealed a rare MEC-specific fusion (CRTC3-MAML2) in NSCLC


Aug
28
2015

Evolution of NGS-based detection of fusions, SNVs and CNVs using Anchored Multiplex PCR

Brian Kudlow, PhD, discusses the challenges of cancer genomics and how Archer technology addresses those challenges in the laboratory. Dr. Kudlow also discuss what Archer technology is moving towards in the future.


Aug
28
2015

Serendipity or preparedness?

By running experiments to change the FusionPlex protocol, a rare fusion known as CRTC3-MAML2, which is typically found in mucoepidermoid carcinomas, was found in all 10 replicates in a lung tumor sample.


Jul
22
2015

When career and passion gracefully collide

Over the past six months of working at Archer, I have become increasingly proud and excited to work for a company whose underlying mission is aligned with mine.


Jul
22
2015

RNA Fusion Sensitivity Analysis

Here we describe a sensitivity experiment we conducted with a custom panel we designed for the detection of gene fusions in the ALK, BDNF, NGF, NGFR, NTF3, NTRK1,2 and 3, RET and ROS1 genes that are often found to be involved in various lung cancers.


Jul
16
2015

Archer Analysis Software Webinar by Thon deBoer

New features discussed include the ability to probe DNA/RNA mutations and enumerate copy number variations, graphical metrics output, and better progress indications


Jun
23
2015

Dr. Kudlow speaks at Festival of Genomics, 2015

Seminar: Comprehensive tumor profiling: a targeted approach using purpose-built technology


May
22
2015

Beyond Fusions - Webinar by Josh Stahl

Josh Stahl, Vice-President of R&D and Scientific Operations at ArcherDX, describes the benefits of AMP chemistry and how it is best suited for DNA-based mutation detection. He will also discuss how Archer VariantPlex assays detect CNVs from DNA, and how combining FusionPlex and VariantPlex assays maximizes mutation detection from a single FFPE sample.

How to contact us

Address

2477 55th Street, Suite 202

Boulder, CO 80301

Phone

Phone: (877) 771 1093

Phone: (303) 357 9001

All content © 2018 ArcherDX, Inc.

For Research Use Only. Not for use in diagnostic procedures. For Research Use Only. Not for use in diagnostic procedures.